文献速递类风湿关节炎

类风湿关节炎与甲状腺癌风险:一项全国性队列研究

Rheumatoid Arthritis and Risk of Thyroid Cancer: A Nationwide Cohort Study.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2025-08-11

该全国性队列研究纳入2010至2017年新诊断的40895例类风湿关节炎(RA)患者,按性别和年龄1:5匹配204475名无RA对照,随访5.5年。整体RA患者甲状腺癌调整风险比(aHR)为0.98(95%CI 0.85-1.13),与对照无显著差异;血清阳性较血清阴性RA患者甲状腺癌风险aHR为1.03(95%CI 0.78-1.36),无显著差异;按年龄或性别分层未见统计学交互作用。

要点

  • 新诊断RA患者甲状腺癌风险与匹配对照无显著差异(aHR 0.98,95%CI 0.85-1.13)。
  • 血清阳性较血清阴性RA患者甲状腺癌风险无显著差异(aHR 1.03,95%CI 0.78-1.36)。
  • 按年龄或性别分层分析未见统计学交互作用。

核心结论

  • 新诊断RA患者与匹配对照相比甲状腺癌风险无显著差异。
  • 甲状腺癌发病风险不受RA血清学状态、性别或年龄影响。

研究设计与样本

  • 利用全国性数据库识别2010至2017年新诊断的40895例RA患者,按性别和年龄1:5匹配204475名无RA对照。
  • 采用Cox回归分析甲状腺癌与RA(考虑血清学状态)的关联,并按性别和年龄进行分层分析。

主要发现

  • 随访5.5年期间,整体RA患者较匹配对照的甲状腺癌aHR为0.98(95%CI 0.85-1.13)。
  • 血清阳性RA患者较血清阴性RA患者的甲状腺癌aHR为1.03(95%CI 0.78-1.36)。
  • 按年龄或性别分层分析未见统计学交互作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite extensive cancer-related research in patients with rheumatoid arthritis (RA), there remains a paucity of studies on thyroid cancer in patients with RA. We investigated the risk of thyroid cancer in patients with RA using updated definitions to identify patients with RA and incident cases of thyroid cancer with consideration of RA serologic status. METHODS: Using a nationwide database, we identified 40,895 patients with newly diagnosed RA between 2010 and 2017 and matched them by sex and age at a 1:5 ratio to a control population of 204,475 individuals without RA. The association of thyroid cancer and RA with consideration of serostatus was investigated using Cox regression analyses. Stratified analyses by sex and age were conducted using the same Cox modeling. RESULTS: During 5.5 years of follow-up, compared to the matched control group, the adjusted hazard ratio (aHR) of thyroid cancer in patients with overall RA was 0.98 (95% confidence interval [CI] 0.85-1.13). Compared to the seronegative patients with RA, seropositive patients with RA did not show a significantly different risk of thyroid cancer (aHR 1.03, 95% CI 0.78-1.36). Stratified analyses by age or sex showed no statistical interaction. CONCLUSION: Patients with newly diagnosed RA did not show a different risk of thyroid cancer compared to a matched control group. The risk of thyroid cancer incidence was not affected by serologic status of RA, sex, or age.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Cho MH, Jung J, Kim TH, et al. Rheumatoid Arthritis and Risk of Thyroid Cancer: A Nationwide Cohort Study. Arthritis Care Res (Hoboken). 2025. PMID: 40511527. doi:10.1002/acr.25582

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。